INT284157

Context Info Confidence 0.08 First Reported 2008 Last Reported 2008 Negated 0 Speculated 1 Reported most in Body Documents 1 Total Number 1 Disease Relevance 1.08 Pain Relevance 0.21

plasma membrane (BBS2) cytoplasm (BBS2)

BBS2 (Homo sapiens)

Pain Link Frequency Relevance Heat Inflammation 7 95.52 cINOD 2 62.24 cytokine 1 54.60 corticosteroid 2 35.48 acular 3 18.16 depression 2 5.00 Inflammatory response 2 5.00 agonist 1 5.00

Disease Link Frequency Relevance Heat Bardet-biedl Syndrome 2 100.00 Pneumonia 2 95.52 INFLAMMATION 8 89.20 Burns 19 76.56 Increased Venous Pressure Under Development 4 70.40 Hypoxia 2 69.72 Injury 40 61.04 Smoke Inhalation Injury 2 53.28 Pulmonary Edema 6 24.88 Edema 6 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

To reduce nitric oxide production, Enkhbaatar and colleagues (2003) examined the use of an iNOS inhibitor, BBS-2, on sheep.

Spec (examined) Regulation (use) of Spec (examined) Negative_regulation (inhibitor) of BBS-2 associated with bardet-biedl syndrome

1) Confidence 0.08 Published 2008 Journal Drug design, development and therapy Section Body Doc Link PMC2761179 Disease Relevance 1.08 Pain Relevance 0.21

General Comments

This test has worked.